Pfizer
shotThere
COVID-19
Moderna
pandemicJohnson & Johnson Chief Scientific
J&J
Business Insider
Healthcare
Telehealth Industry
Healthcare
Remote Patient Monitoring
Business Insider Intelligence
Drugmakers
Paul Stoffels
Moncef Slaoui
Pfizer
No matching tags
No matching tags
New York
Massachusetts
US
Telehealth Industry
Value-Based Care
Senior Care & Assisted Living Market
Medical Devices & Wearable Tech
Pfizer is setting plans to make its coronavirus vaccine available to more groups of people, should the pharma company prove that the shot works to prevent the virus.On Monday, the company said on its website that it got approval from regulators to expand a trial of the shot to include children as young as 12, becoming the first major drugmaker to open a coronavirus vaccine trial to kids. Read more: Coronavirus-vaccine frontrunner Moderna is planning to start testing its shot in kids — a crucial step to halting the pandemicJohnson & Johnson Chief Scientific Officer Paul Stoffels said J&J is committed to running pediatric trials. J&J started the final stage of trials in September.Moncef Slaoui, the chief scientist overseeing the US government's coronavirus vaccine initiative, told Business Insider he believes a vaccine needs to show it can work in adults before being tried in large numbers of children.
As said here by Andrew Dunn